🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cogent Biosciences, Inc.

COGT Healthcare
$26.72 $-1.02 (-3.70%)
Market Cap: $4.65 B
Gurus Holding
5
Popularity Rank
#1747
% of Shares Held
1.17%
Net Activity (Q3 2026)
-$13.21 M

Guru Ownership Trend

Guru Analysis for Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $54.36 M.

Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $13.21 M net outflow during the quarter.

Recent activity highlights Stanley Druckenmiller who opened a new position. Conversely, Cliff Asness reduced exposure by 45.0%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$8.56 M
Total Buy Value
New Buys 1
Additions 1
-$21.78 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for Cogent Biosciences, Inc. (COGT)

Major holders include Steven Cohen ($25.31 M), Renaissance Technologies (RenTech) ($22.69 M), Stanley Druckenmiller ($7.08 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.03 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $13.21 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited COGT. The total reported sell value was $21.78 M.

Yes, 1 managers opened new positions in COGT, and 1 increased their existing holdings. The total reported buy value was $8.56 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Add 6.2% 790,494 $25.31 M Q3 2026
0.03% Reduce -28.9% 708,668 $22.69 M Q3 2026
0.16% New Buy 221,112 $7.08 M Q3 2026
0.00% Reduce -45.0% 162,112 $5.19 M Q3 2026
0.00% Reduce -17.5% 152,498 $4.88 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form